At JMP Securities, our investment bankers concentrate on six industries—technology, healthcare, financial services, real estate, consumer, and industrials.
Our success depends on our ability to evaluate and structure transactions that create long-term shareholder value, and a successful transaction requires us to draw on all of our strengths: exceptional client focus, in-depth industry knowledge, and skilled execution. We are especially proud of our tendency to build lasting relationships with our clients, playing a true advisory role and working on multiple transactions over time.
Our capital raising capabilities include public and private capital markets transactions, including equity, debt, and convertible securities offerings. We also offer a broad range of strategic advisory services, such as mergers and acquisitions (M&A) advisory, divestitures, recapitalizations, and valuations and fairness opinions. In addition, we provide restructuring services, including liability management, debt restructuring, sourcing of new debt and equity capital, asset sales, reorganizations, and distressed M&A.
Gavin Slader is a Managing Director and is head of investment banking at JMP Securities. He also serves as head of mergers and acquisitions. Gavin is a member of the firm’s executive committee.
Prior to joining JMP, Gavin was a senior banker in the technology, media and telecommunications investment banking group at UBS Investment Bank, sharing oversight of the west coast technology mergers and acquisitions practice. Gavin previously held investment banking roles at Piper Jaffray & Co., Credit Suisse First Boston, and Donaldson, Lufkin & Jenrette, concentrating on mergers and acquisitions throughout. He began his Wall Street career in Deutsche Bank’s leveraged finance group.
Gavin holds a BA from Claremont McKenna College, graduating with dual degrees in economics and accounting.
David Kellman is a Managing Director and is head of healthcare investment banking at JMP Securities. He serves on the firm’s investment banking management committee.
David has over 20 years of experience investing in and advising healthcare and life sciences companies. Since joining JMP, David has executed over 100 advisory and capital markets transactions.
Prior to joining JMP, David was a Vice President at Paramount BioSciences, a life sciences investment firm. Previously, he was a hedge fund analyst at S.A.C. Capital Advisors focused on healthcare investing and a member of the healthcare investment banking group at Piper Jaffray. David began his career in the healthcare group of Investor Growth Capital, the venture capital arm of Investor AB.
David holds a BS in finance from the University of Pennsylvania’s Wharton School and a BSE in bioengineering from its School of Engineering and Applied Science.
Kevin McClelland is a Managing Director and is head of technology investment banking at JMP Securities. He serves on the firm’s investment banking management committee.
Prior to joining JMP, Kevin was Principal at Broadview International, a technology-focused M&A advisory firm, where he led the firm’s west coast infrastructure software practice, concentrating on buy-side and sell-side transactions, divestitures, private placements, and strategic advisory assignments. Kevin previously worked for Andersen Consulting, now Accenture, designing and implementing custom and off-the-shelf software applications.
Kevin holds an MBA from Harvard Business School, a BS in electrical engineering from the University of Illinois and a BA from Wheaton College.
Ryan Abbe is a Managing Director and is head of real estate investment banking at JMP Securities.
Ryan rejoined JMP in early 2022, following two years at UBS, where he was a Managing Director in the real estate investment banking group. Ryan spent the previous 16 years at JMP Securities, working with equity REITs, property technology and real estate services companies, homebuilders, and land developers. He began his career at Piper Jaffray as a member of the financial institutions investment banking group.
Ryan holds a BA in economics from Macalester College.
Jim Alfaro is a Managing Director in JMP Securities’ healthcare investment banking group.
Prior to joining JMP, Jim was a Senior Managing Director and head of healthcare investment banking at Maxim Group. He previously served as a senior member of the healthcare investment banking group at Wedbush Morgan Securities, after working in both equity capital markets and mergers and acquisitions at J.P. Morgan Securities.
Jim holds an MBA from the University of California, Berkeley, and a BBA from the University of Texas at Austin.
Gianpaolo Arpaia is a Managing Director in the equity capital markets division at JMP Securities, overseeing convertible and equity-linked securities activities.
Satya Bajpai is a Managing Director in JMP Securities’ investment banking group focused on mergers and acquisitions.
Fedora Baloiu is a Managing Director in JMP Securities’ healthcare investment banking group and serves as co-head of biopharma corporate finance.
Prior to joining JMP, Fedora was a Managing Director and head of U.S. healthcare investment banking at Nomura Securities. She previously served as head of the biopharmaceuticals practice at Houlihan Lokey, after spending nearly a decade in the healthcare investment banking division at Goldman Sachs & Co. She began her career as a consultant at Bain & Company in Milan, Italy.
Fedora holds a master’s degree in biotechnology from Johns Hopkins University, an MBA from Columbia Business School, and an undergraduate business degree from Italy’s Bocconi University.
Eric Clark is a Managing Director in JMP Securities’ real estate investment banking group.
Bard Cook is a Managing Director and is head of debt markets and advisory at JMP Securities.
Bard has over 30 years of experience assisting corporate issuers in accessing the capital markets for a wide range of debt instruments, including public/Rule 144A investment grade and high yield bonds, hybrid capital securities, private senior and subordinated notes, institutional leveraged loans, syndicated and club lending facilities, and asset backed securities.
Prior to joining JMP, Bard was a Managing Director at RBC Capital Markets, where he established its U.S. corporate debt business and during his tenure was responsible for the firm’s high yield, private placement and investment grade debt capital markets groups. He previously ran Mellon Bank’s placement division and held several positions in corporate banking.
Bard holds a BA from Yale University.
Jason Luce is a Managing Director in JMP Securities’ technology investment banking group with a focus on cybersecurity and infrastructure software.
Andy Mertz is a Managing Director and head of equity capital markets at JMP Securities.
Prior to joining JMP, Andy was a Managing Director in equity capital markets at Cowen and Company, where he oversaw equity financing activity in the technology and healthcare verticals and, earlier in his career, served as head of equity syndicate. He previously held equity capital markets positions at Robertson Stephens and Bear, Stearns & Co.
Andy holds an MBA from Fordham University and a BBA from Pace University.
Jorge Solares-Parkhurst is a Managing Director in JMP Securities’ financial services investment banking group.
Prior to joining JMP, Jorge had been a Director in the global financial institutions group at Credit Suisse, where he worked with U.S. specialty lenders and regional banks. He previously served as a Managing Director at FBR Capital Markets and a Senior Managing Director at Bear, Stearns & Co. Jorge began his career in PaineWebber’s investment banking division, remaining with the firm following its acquisition by UBS and concluding his tenure there as a Director in the financial institutions group for the Americas.
Jorge holds a BSFS in international economics from The Edmund A. Walsh School of Foreign Service at Georgetown University.
Alan Tekerlek is a Managing Director in JMP Securities’ technology investment banking group.
Prior to joining JMP, Alan founded and was managing partner of Aspect Partners, a boutique merchant banking firm focused on advising and investing in middle-market companies in a broad range of industries. He was previously a senior member of the global technology group at Lehman Brothers, where he provided capital markets and strategic advisory services to corporate clients in the software and Internet and digital media sectors, among others. Earlier in his career, Alan worked in corporate finance and restructuring at GE Capital Corporation and in strategy consulting at Theodore Barry & Associates.
Alan holds a BA from University of California, Los Angeles.
Elgin Thompson is a Managing Director in JMP Securities’ technology investment banking group.
Prior to joining JMP, Elgin was a Managing Director at Digital Capital Advisors, an advisory boutique focused on emerging technology companies. Elgin previously served as Senior Vice President of Strategy and Corporate Development at GridNetworks, a venture-backed Internet infrastructure provider, where he was instrumental in negotiating the company’s sale. Earlier in his career, he was a senior member of the technology and media investment banking groups at Bear Stearns and Merrill Lynch and practiced mergers and acquisitions law with DLA Piper and Wildman Harold (now Lord & Locke).
Elgin holds an MBA from the Kellogg School of Management at Northwestern University, a JD from Temple University Beasley School of Law, and a BA from Northern Illinois University.
Julian Carlson is a Director in JMP Securities’ healthcare investment banking group.